Is a
No article content yet.
Timeline
No Timeline data yet.
Invested in
Patents
Further Resources
No Further Resources data yet.
Andrew Leber, Ph.D. contributes deep knowledge of immunology, advanced computational modeling, data analytics, AI, and drug development to Landos Biopharma. As the Executive Scientific Director, he is responsible for assessing the therapeutic potential of lead immunoregulatory targets in autoimmune diseases.